← All indications
Staphylococcal Infections
Infections with bacteria of the genus STAPHYLOCOCCUS.
Subtype terms (3)
More specific conditions that are subtypes of Staphylococcal Infections in the MeSH hierarchy.
- Pneumonia, Staphylococcal
19 drugs (11 approved, 8 experimental)
- Staphylococcal Food Poisoning
- Staphylococcal Skin Infections
38 drugs (31 approved, 7 experimental)
Drugs by status
Approved for this indication (9)
Phase 4 trials (26)
- edoxaban
- ceftaroline fosamil
- dabigatran
- cefazolin
- fosfomycin
- rifampin
- albumin (Human)
- tigecycline
- daptomycin
- iodine
- mupirocin
- immune globulin (human)
- ceftriaxone
- oritavancin
- acetylsalicylic acid
- teicoplanin
- rivaroxaban
- apixaban
- clopidogrel
- clindamycin
- cephalexin
- cloxacillin
- chlorhexidine
- benzathine penicillin
- benzylpenicillin
- polyethylene glycol
Phase 3 trials (12)
Phase 2 trials (22)
- omodenbamab
- argatroban
- tefibazumab
- brilacidin
- gabapentin
- human lactoferrin peptide
- kbsa301
- ltx-109
- s. aureus immune globulin
- staphylococcus aureus immune globulin
- td1792
- enoxaparin
- v710
- Exeporfinium
- sa3ag
- sa4ag vaccine
- staphylococcus aureus 4-antigen vaccine
- anti-staphylococcus bacteriophage therapy
- nafcillin
- ertapenem
- tonabacase
- DUOFAG
Phase 1 trials (12)
Organizations
Organization Involved with Phase 4 Indications (41)
- 3M
- Forest Laboratories
- Pfizer
- CPL Associates
- Cubist
- GlaxoSmithKline
- Destiny Pharma Ltd
- University of Pennsylvania
- CAMC Health System
- Harvard University
- East Tennessee State University
- Emory University
- Johns Hopkins University
- Mahidol University
- Mountain Home Research & Education Corporation
- Northwestern University
- Ochsner Health System
- Osaka University
- Saint Joseph Mercy Health System
- Siriraj Hospital
- Tulane University
- University of Iowa
- University of Michigan
- University of Oslo
- West Virginia University
- University of California, Irvine
- University of Munster
- Jiao Tong University
- University of Toulouse
- National Taiwan University
- +11 more
Organization Involved with Phase 3 Indications (16)
- Theravance
- Biosynexus Incorporated
- Nabi Biopharmaceuticals
- NeuTec Pharma
- German Research Foundation
- National Cancer Institute (NCI)
- National Institute of Allergy and Infectious Diseases (NIAID)
- Public Health England
- Duke University
- Kaiser Permanente
- Los Angeles Biomedical Research Institute
- University of Leeds
- Tel Aviv University
- University of California, Los Angeles
- Vanderbilt University
- University of Duesseldorf
Organization Involved with Phase 2 Indications (27)
- AM-Pharma
- Bio-K Plus International Inc.
- CF Therapeutics Development Network Coordinating Center
- Nitric BioTherapeutics, Inc
- Pherecydes Pharma
- R. Stephen Rankin, M.D.
- Centre Hospitalier Universitaire Vaudois
- Baylor University
- Centre Hospitalier Universitaire de Nīmes
- University of Washington
- Radboud University
- Seoul National University
- University of Florida
- University of Lausanne
- Cardiff University
- University of Cincinnati
- University of Colorado, Denver
- Rankin, R. Stephen, M.D.
- Cook Children's Medical Center
- Karolinska Institute
- University of North Carolina at Chapel Hill
- Pierre Le Gardeur Hospital
- University of Alabama, Birmingham
- Kantonsspital Liestal
- Schulthess Klinik
- Centre Hospitalier Pierre-Le Gardeur
- The University of Texas, Dallas
Organization Involved with Phase 1 Indications (7)
Organization Involved with Other Experimental Indications (32)
- Bristol-Myers Squibb
- Inhibitex
- United States Army
- Uniformed Services University of the Health Sciences
- United States Air Force
- Rockefeller University
- Cancer Research Network
- Centre Jean Perrin
- Centre Leon Berard
- University of London
- Clinical Directors Network
- Horizon Health Network
- Mercy Research
- Thomas Jefferson University
- University of British Columbia
- University of California, San Francisco
- CHU Henri Mondor
- Hospital Corporation of America
- Pennsylvania State University
- University of Nice Sophia Antipolis
- Mercy/St. John's Hospital - Springfield
- University of Paris
- Humboldt University
- Emergency Medicine Foundation
- Sage Products, Inc.
- CHG Jacques Lacarin (Vichy)
- State of Pennsylvania
- University of Grenoble
- Centers for Disease Control and Prevention (CDC)
- Becton Dickinson
- +2 more